These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 12149466)
61. [Antiangiogenic therapy]. Toi M Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900 [TBL] [Abstract][Full Text] [Related]
62. Chemical genomics-based target identification and validation of anti-angiogenic agents. Kwon HJ Curr Med Chem; 2003 May; 10(9):717-36. PubMed ID: 12678774 [TBL] [Abstract][Full Text] [Related]
63. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. O'Reilly MS EXS; 1997; 79():273-94. PubMed ID: 9002223 [TBL] [Abstract][Full Text] [Related]
64. Angiogenesis research yields new approaches to cancer treatment and prognosis. Larsen NS J Natl Cancer Inst; 1993 Oct; 85(20):1629-30. PubMed ID: 7692073 [No Abstract] [Full Text] [Related]
65. Injection of antiangiogenic agents into the macaque preovulatory follicle: disruption of corpus luteum development and function. Hazzard TM; Rohan RM; Molskness TA; Fanton JW; D'Amato RJ; Stouffer RL Endocrine; 2002 Apr; 17(3):199-206. PubMed ID: 12108520 [TBL] [Abstract][Full Text] [Related]
66. [Angiostatin. A biological inhibitor of tumor angiogenesis]. Thimme R; Spangenberg HC; Blum HE Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915 [No Abstract] [Full Text] [Related]
67. Docosahexaenoic acid attenuates adipose tissue angiogenesis and insulin resistance in high fat diet-fed middle-aged mice via a sirt1-dependent mechanism. Luo X; Jia R; Yao Q; Xu Y; Luo Z; Luo X; Wang N Mol Nutr Food Res; 2016 Apr; 60(4):871-85. PubMed ID: 26750093 [TBL] [Abstract][Full Text] [Related]
68. Role of angiogenesis in tumor growth and metastasis. Folkman J Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034 [TBL] [Abstract][Full Text] [Related]
69. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice. Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675 [TBL] [Abstract][Full Text] [Related]
70. [Angiogenesis and its inhibitors]. Ono M; Kuwano M Gan To Kagaku Ryoho; 1997 Sep; 24(11):1585-93. PubMed ID: 9309158 [TBL] [Abstract][Full Text] [Related]
71. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Drevs J; Hofmann I; Hugenschmidt H; Wittig C; Madjar H; Müller M; Wood J; Martiny-Baron G; Unger C; Marmé D Cancer Res; 2000 Sep; 60(17):4819-24. PubMed ID: 10987292 [TBL] [Abstract][Full Text] [Related]
73. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788 [TBL] [Abstract][Full Text] [Related]
74. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli. You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278 [TBL] [Abstract][Full Text] [Related]
75. [The clinical perspective of angiogenesis inhibitors]. Radema SA; Witteveen PO; Gebbink MB; Voest EE Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538 [TBL] [Abstract][Full Text] [Related]
76. Neuregulin-4 is an angiogenic factor that is critically involved in the maintenance of adipose tissue vasculature. Nugroho DB; Ikeda K; Barinda AJ; Wardhana DA; Yagi K; Miyata K; Oike Y; Hirata KI; Emoto N Biochem Biophys Res Commun; 2018 Sep; 503(1):378-384. PubMed ID: 29902456 [TBL] [Abstract][Full Text] [Related]
77. Treatment of human pancreatic cancer in mice with angiogenic inhibitors. Prox D; Becker C; Pirie-Shepherd SR; Celik I; Folkman J; Kisker O World J Surg; 2003 Apr; 27(4):405-11. PubMed ID: 12658482 [TBL] [Abstract][Full Text] [Related]
78. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis. Matsuno H; Yudoh K; Uzuki M; Nakazawa F; Sawai T; Yamaguchi N; Olsen BR; Kimura T J Rheumatol; 2002 May; 29(5):890-5. PubMed ID: 12022345 [TBL] [Abstract][Full Text] [Related]
79. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. Kato T; Sato K; Kakinuma H; Matsuda Y Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956 [TBL] [Abstract][Full Text] [Related]
80. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]